Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes Aug. 21, 2014
Eli Lilly and Boehringer Ingelheim's insulin glargine receives tentative approval from the FDA Aug. 19, 2014
Conditional marketing authorization in E.U. for Translarna in Duchenne muscular dystrophy Aug. 6, 2014
RSS